company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,474092.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,50999.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,525091.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-525091.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,510285.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,76716.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2808996.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2375427.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1850336.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1850336.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1850336.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1850336.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2400000.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.77
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2400000.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.77
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2408594.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q2,2010-04-01,2010-06-30,2011-09-14 12:44:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.77
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,297000.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,297000.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-297000.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-297000.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-297000.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-297000.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-14895.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-282105.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1900000.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1900000.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1822154.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q2,2011-04-01,2011-06-30,2012-09-07 16:01:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14175.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15940.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30115.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30115.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30115.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30115.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30115.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1510.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28605.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2900000.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2900000.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2632000.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 16:37:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,644001.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16741353.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17385354.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17385354.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,220149.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3668.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,205297.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11184.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17396538.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17396538.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17396538.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-7140448.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10256090.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,5100000.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.03
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,5100000.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.03
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,5061399.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.03
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1458836.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1646094.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3104930.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3104930.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,228109.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4092.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,754788.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,530771.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2574159.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2574159.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2574159.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-679506.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1894653.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,11800000.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11800000.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,11777563.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 16:31:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1153424.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1560802.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2714226.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2714226.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,228585.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4951.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,227659.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4025.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2710201.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2710201.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2710201.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-247962.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2462239.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15400000.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15400000.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15810299.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,2013-11-14 16:14:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19048.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19048.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19048.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1525195.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1079742.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1104700.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3709637.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3690589.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,228901.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3076.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,744360.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,518535.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3172054.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,330000.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3502054.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3502054.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-42317.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3459737.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13100000.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13100000.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13113758.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2182231.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1569905.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3752136.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3714041.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,231472.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1502.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,270400.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,40430.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3673611.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3673611.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3673611.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3673611.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21600000.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21600000.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21953803.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1639237.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5027623.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6666860.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6628765.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,240014.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1177.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,283050.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,44213.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6584552.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6584552.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6584552.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6584552.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22700000.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22700000.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22483394.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 16:36:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38096.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38096.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38096.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1375952.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3309561.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4685513.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4647417.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,240530.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12375.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,319377.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,91222.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4556195.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4556195.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4556195.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4556195.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28500000.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28500000.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27684802.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,2014-11-14 16:01:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1460670.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3755591.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2797600.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8013861.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7975766.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,240872.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15768.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2537018.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2311914.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5663852.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5663852.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5663852.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5663852.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25300000.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25300000.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25413964.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3233352.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4409868.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7643220.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7605125.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,226340.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13474.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,270742.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,57876.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7547249.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7547249.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7547249.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7547249.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30200000.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30200000.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30091000.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5145460.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6848132.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11993592.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11955497.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,234787.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12727.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,191127.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-30933.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11986430.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11986430.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11986430.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11986430.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33300000.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33300000.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32985130.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:01:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38096.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38096.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38096.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3785869.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13691573.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17477442.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17439346.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,234787.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12107.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,210857.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11823.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17451169.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17451169.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17451169.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17451169.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34200000.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34200000.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34188108.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:01:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3622445.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15136774.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18759219.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18721124.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-695914.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16741.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-787960.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-75305.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18796429.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18796429.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18796429.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18796429.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34000000.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34000000.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.52
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34068926.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.52
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5023607.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9617339.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14640946.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14602851.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,237657.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,22132.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,240641.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,25116.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14577735.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14577735.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14577735.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14577735.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41700000.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41700000.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41088752.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5888015.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11261660.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17149675.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17111580.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,246526.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31551.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,223372.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8397.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17103183.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17103183.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17103183.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17103183.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45000000.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45000000.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45320637.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:01:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38096.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38096.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38096.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2289678.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11574002.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13863680.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13825584.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,246527.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,55977.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,360218.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,169668.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13655916.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13655916.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13655916.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13655916.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48800000.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48800000.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47946309.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:01:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2423874.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15254222.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17678096.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17640001.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-730710.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,64993.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-767514.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,28189.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17611812.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17611812.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17611812.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17611812.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45600000.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45600000.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.37
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45646414.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2412911.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11617340.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14030251.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13992156.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,84862.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,58632.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,143494.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13848662.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13848662.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13848662.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13848662.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49500000.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49500000.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48908278.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38095.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2527807.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13533731.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16061538.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16023443.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,92629.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,31752.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,124381.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15899062.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15899062.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15899062.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15899062.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48200000.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48200000.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48769948.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:06:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38096.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38096.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38096.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3165811.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21797756.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24963567.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24925471.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,87965.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6479.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,94444.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24831027.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24831027.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24831027.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24831027.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49700000.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.5
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49700000.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.5
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49203277.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:32:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.5
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,37714.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,37714.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,37714.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1782471.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22283173.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24065644.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24027930.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,57544.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,296137.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,353681.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23674249.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23674249.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23674249.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23674249.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48900000.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48900000.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49041354.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5022000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22682000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27704000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27666000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,45000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-106000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-61000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27727000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27727000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27727000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27727000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53300000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53300000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.52
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,53157851.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.52
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1757000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26706000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28463000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28425000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,50000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,22000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,72000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28353000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28353000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28353000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28353000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63000000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63000000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63288269.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:31:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4474000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27149000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31623000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-31585000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,79000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-30000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,49000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31536000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31536000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31536000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31536000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65700000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.48
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65700000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.48
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,65079128.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 16:01:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.48
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5078000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25996000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31074000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-31036000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,845000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-174000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1195000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,176000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30860000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30860000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30860000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30860000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62000000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62000000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62069570.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6597000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35018000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41615000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41577000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,144000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-96000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,48000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-41529000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41529000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41529000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41529000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70400000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.59
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,70400000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.59
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70636970.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.59
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,968000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33398000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34366000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-34328000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,221000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,598000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,377000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33951000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33951000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33951000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33951000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,79000000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.43
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,79000000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.43
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,78221069.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 17:27:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.43
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2342000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32385000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34727000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-34689000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,774000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,307000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-467000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35156000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35156000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35156000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-35156000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,81800000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.43
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,81800000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.43
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,81174301.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.43
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2914000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,57985000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60899000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-60861000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1537000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,468000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1069000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-61930000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61930000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61930000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-61930000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,89800000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.69
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,89800000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.69
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,89667979.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 17:27:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.69
